NIH-funded research R21 grant

Targeting specific nerves to reduce pain and mouth sores from radiation therapy

Official title: Targeting TRPV1-containing nerves for radiation-induced pain and oral mucositis

Funded at University of Pittsburgh at Pittsburgh · NIH-10950683 · Data updated 2026-11-12

This study is looking at how to help people with head and neck cancer who experience painful mouth sores and burning pain during radiation therapy, by exploring new ways to ease their discomfort and improve their quality of life.

More Oral Mucositis research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startJuly 1, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$198,750
NIH project number1R21DE034106-01
Project IDNIH-10950683 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients receiving radiation therapy for head and neck cancer who experience pain and oral mucositis.

Less likely to help

Patients who are not undergoing radiation therapy or those with other types of cancer unrelated to head and neck may not benefit from this research.

What this research studies

This research focuses on addressing the pain and oral mucositis that often occur in patients undergoing radiation therapy for head and neck cancer. It aims to investigate the role of TRPV1-containing nerves in these conditions, as many patients report severe burning pain during and after treatment. By developing preclinical models, the research will evaluate new therapeutic options to alleviate pain and improve the quality of life for affected patients. The study will also explore the relationship between nerve density and the severity of symptoms.

Why it matters

Potential benefit: If successful, this research could lead to more effective pain management strategies for patients undergoing radiation therapy for head and neck cancer.

How similar studies have gone: Previous studies have shown promise in targeting TRPV1 nerves for pain relief, indicating potential for success in this novel approach.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Scheff, Nicole N — University of Pittsburgh at Pittsburgh
  • Study coordinator: Scheff, Nicole N

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.